CHINA RESOURCES SANJIU MEDICAL & PHARMACEUTICAL CO., LTD.

Altre lingue China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

Azioni

000999

CNE0000011K8

Prezzo di chiusura Shenzhen S.E. Altri mercati azionari 00:00:00 26/04/2024			Variaz. 5gg	Var. 1 gen.
60,78 ^CNY	+0,46%		+2,58%	+22,22%

19/04	China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI
25/03	L'utile di CR Sanjiu per il 2023 sale del 16,5%, il fatturato salta del 37%	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	19/04
CR Sanjiu's 2023 Profit Climbs 16.5%, Revenue Jumps 37%	25/03
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Proposes Cash Dividend	25/03
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	22/03
China Resources Sanjiu Sees Up to 32% Jump in 2023 Profit	25/01
CR Sanjiu Expects Increase in 2023 Profit	25/01
Chongqing Changsheng Shenghe Pharmaceutical Private Equity Investment Fund Partnership Enterprise and China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. agreed to acquire 18.7751% stake in Runsheng Pharmaceutical Co., Ltd. from Chongqing Boyi Xintian Equity Investment Fund Partnership Enterprise (Limited Partnership), Tasly Capital and Chongqing Juxin Investment Co., Ltd. for CNY 58.9 million .	06/01
Respirent Pharmaceutical Co.,Ltd. announced that it expects to receive CNY 127.97619 million in funding from China Resources Sanjiu Medical & Pharmaceutical Co., Ltd., Chongqing Changsheng Shenghe Pharmaceutical Private Equity Investment Fund Partnership Enterprise	04/01
China Resources Power Unit to Provide Financial Assistance to Affiliate	12/12
CR Sanjiu Medical & Pharmaceutical Unit's Hypertension Drug Chosen for China's Centralized Procurement	08/11
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	27/10/23
China Resources Sanjiu to Invest Up to 3.5 Billion Yuan in Bank Financial Products	06/10/23
CR Sanjiu Medical & Pharmaceutical's H1 Attributable Profit Rises 31%	30/08/23
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	29/08/23
CR Sanjiu Medical’s Analgesic Tablet Shortlisted For China’s Drug Procurement Program	27/06/23
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Announces Implementation of Cash Dividend for 2022, Payable on 15 June 2023	08/06/23
China Resources Sanjiu Medical & Pharmaceutical's Q1 Net Profit Surges	02/05/23
China Resources Power to Cooperate on New Energy Projects with China Resources Sanjiu Medical	01/05/23
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	28/04/23
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Enters into the Cooperation Agreement with China Resources Power Holdings Company Limited	28/04/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

Azioni

000999

CNE0000011K8

Altre lingue

Filtri